Chr Hansen A/S : Financial calendar 2015/16

Company announcement no.15/2015

2015

21 October Annual Report 2014/15

26 November Annual General Meeting

Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Wednesday 14 October at 16.00 CET.

2016

14 January Interim Report (Q1 2015/16)

7 April Interim Report (Q2 2015/16)

5 July Interim Report (Q3 2015/16)

26 October Annual Report 2015/16

29 November Annual General Meeting

Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday, 17 October at 16.00 CET.

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations
Tel: [phone]

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr.Nasdaq Copenhagen. For further information, please visitwww.chr-hansen.com .